North East and North Cumbria
ICS Formulary
 
back
6 Endocrine system
06-05-02 Posterior pituitary hormones and antagonists

Tolvaptan
Formulary
  • 15mg, 30mg, 45mg, 60mg and 90mg tablets (Jinarc®) - approved for the treatment of autosomal dominant polycystic kidney disease in line with NICE.
  • 15mg and 30mg tablets (Samsca®) - approved for the treatment of hyponatraemia secondary to the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) in patients requiring cancer chemotherapy in accordance with NHS England Policy.
Link  NICE TA358: Autosomal dominant polycystic kidney disease - tolvaptan

Red View adult BNF  View SPC online  View childrens BNF  HCD